亚太药业
(002370)
| 流通市值：38.18亿 | | | 总市值：38.18亿 |
| 流通股本：7.46亿 | | | 总股本：7.46亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 515,374,869.12 | 586,461,867.98 | 618,719,305.59 | 587,809,931.97 |
| 结算备付金 | 0 | - | 0 | - |
| 拆出资金 | 0 | - | 0 | - |
| 交易性金融资产 | 9,239 | 30,055,997.81 | 0 | 30,082,329.42 |
| 衍生金融资产 | 0 | - | 0 | - |
| 应收票据及应收账款 | 110,169,682.83 | 95,596,113.21 | 91,415,725.07 | 103,548,761.89 |
| 其中：应收票据 | 0 | - | 0 | - |
| 应收账款 | 110,169,682.83 | 95,596,113.21 | 91,415,725.07 | 103,548,761.89 |
| 应收款项融资 | 35,631,857.17 | 29,920,118.52 | 63,633,932.59 | 28,969,559.17 |
| 预付款项 | 11,380,091.36 | 2,487,019.28 | 4,036,888.6 | 1,346,589.33 |
| 应收保费 | 0 | - | 0 | - |
| 应收分保账款 | 0 | - | 0 | - |
| 应收分保合同准备金 | 0 | - | 0 | - |
| 其他应收款合计 | 23,349,344.99 | 614,467.95 | 530,189.96 | 3,309,405.58 |
| 其中:应收利息 | 0 | - | 0 | 2,730,243.04 |
| 应收股利 | 0 | - | 0 | - |
| 买入返售金融资产 | 0 | - | 0 | - |
| 存货 | 92,320,363.69 | 100,942,956.17 | 107,251,421.94 | 52,774,054.96 |
| 合同资产 | 0 | - | 0 | - |
| 一年内到期的非流动资产 | 0 | - | 0 | - |
| 其他流动资产 | 6,576,323.01 | 11,978,532.34 | 12,686,882.61 | 8,142,638.68 |
| 流动资产合计 | 794,811,771.17 | 858,057,073.26 | 898,274,346.36 | 815,983,271 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | 0 | - | 0 | - |
| 债权投资 | 0 | - | 0 | - |
| 其他债权投资 | 0 | - | 0 | - |
| 长期应收款 | 0 | - | 0 | - |
| 长期股权投资 | 0 | - | 0 | - |
| 其他权益工具投资 | 0 | - | 0 | - |
| 其他非流动金融资产 | 60,892,655.62 | 36,307,834.05 | 38,012,170.63 | 36,689,365.37 |
| 投资性房地产 | 0 | - | 0 | - |
| 固定资产 | 286,069,433.21 | 289,304,351.18 | 294,713,969.12 | 300,034,190.33 |
| 在建工程 | 2,391,100 | 1,051,080.64 | 16,093 | 1,457,149.83 |
| 生产性生物资产 | 0 | - | 0 | - |
| 油气资产 | 0 | - | 0 | - |
| 使用权资产 | 0 | - | 0 | - |
| 无形资产 | 41,436,317.75 | 42,712,766.3 | 44,001,051.86 | 43,291,544.3 |
| 开发支出 | 5,688,950.96 | 5,453,101.9 | 4,698,384.92 | 16,463,412.82 |
| 商誉 | 0 | - | 0 | - |
| 长期待摊费用 | 0 | - | 0 | 28,080 |
| 递延所得税资产 | 0 | - | 0 | - |
| 其他非流动资产 | 588,000 | - | 0 | - |
| 非流动资产合计 | 397,066,457.54 | 374,829,134.07 | 381,441,669.53 | 397,963,742.65 |
| 资产总计 | 1,191,878,228.71 | 1,232,886,207.33 | 1,279,716,015.89 | 1,213,947,013.65 |
| 流动负债: | | | | |
| 短期借款 | 0 | - | 0 | - |
| 向中央银行借款 | 0 | - | 0 | - |
| 吸收存款及同业存放 | 0 | - | 0 | - |
| 拆入资金 | 0 | - | 0 | - |
| 交易性金融负债 | 0 | - | 0 | - |
| 衍生金融负债 | 0 | - | 0 | - |
| 应付票据及应付账款 | 44,850,153.05 | 76,835,217.14 | 103,966,984.16 | 50,020,424.53 |
| 其中：应付票据 | 5,867,000 | 60,312,032.5 | 60,312,032.5 | 15,348,965 |
| 应付账款 | 38,983,153.05 | 16,523,184.64 | 43,654,951.66 | 34,671,459.53 |
| 预收款项 | 0 | - | 0 | - |
| 合同负债 | 1,516,183.86 | 14,155,462.75 | 14,746,447.04 | 2,138,035.77 |
| 卖出回购金融资产款 | 0 | - | 0 | - |
| 应付手续费及佣金 | 0 | - | 0 | - |
| 应付职工薪酬 | 7,009,331.73 | 6,194,273.57 | 13,133,450.16 | 7,600,219.47 |
| 应交税费 | 951,418.6 | 1,631,664.17 | 5,146,980.69 | 1,965,646.47 |
| 其他应付款合计 | 8,022,887.9 | 7,873,822.7 | 13,325,849.4 | 17,455,571.62 |
| 其中:应付利息 | 0 | - | 0 | - |
| 应付股利 | 0 | - | 0 | - |
| 应付分保账款 | 0 | - | 0 | - |
| 保险合同准备金 | 0 | - | 0 | - |
| 代理买卖证券款 | 0 | - | 0 | - |
| 代理承销证券款 | 0 | - | 0 | - |
| 一年内到期的非流动负债 | 0 | - | 0 | - |
| 其他流动负债 | 197,103.9 | 1,840,210.17 | 1,917,038.07 | 277,944.65 |
| 流动负债合计 | 62,547,079.04 | 108,530,650.5 | 152,236,749.52 | 79,457,842.51 |
| 非流动负债: | | | | |
| 长期借款 | 0 | - | 0 | - |
| 应付债券 | 0 | - | 0 | - |
| 优先股 | 0 | - | 0 | - |
| 永续债 | 0 | - | 0 | - |
| 租赁负债 | 0 | - | 0 | - |
| 长期应付款 | 0 | - | 0 | - |
| 长期应付职工薪酬 | 0 | - | 0 | - |
| 预计负债 | 0 | - | 0 | 6,037,827.67 |
| 递延收益 | 2,644,257.64 | 2,927,570.98 | 3,210,884.32 | 3,494,197.66 |
| 递延所得税负债 | 2,913,571.47 | 3,725,848.24 | 3,981,498.73 | 3,783,077.92 |
| 其他非流动负债 | 0 | - | 0 | - |
| 非流动负债合计 | 5,557,829.11 | 6,653,419.22 | 7,192,383.05 | 13,315,103.25 |
| 负债合计 | 68,104,908.15 | 115,184,069.72 | 159,429,132.57 | 92,772,945.76 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 745,667,530 | 745,667,530 | 745,667,530 | 745,667,530 |
| 其他权益工具 | 0 | - | 0 | - |
| 优先股 | 0 | - | 0 | - |
| 永续债 | 0 | - | 0 | - |
| 资本公积 | 2,005,019,330.65 | 2,005,019,330.65 | 2,005,016,546.65 | 2,005,016,546.65 |
| 减:库存股 | 0 | - | 0 | - |
| 其他综合收益 | 0 | - | 0 | - |
| 专项储备 | 0 | - | 0 | - |
| 盈余公积 | 60,559,514.31 | 60,559,514.31 | 60,559,514.31 | 60,559,514.31 |
| 一般风险准备 | 0 | - | 0 | - |
| 未分配利润 | -1,691,392,182.1 | -1,693,544,237.35 | -1,690,956,707.64 | -1,690,069,523.07 |
| 归属于母公司股东权益合计 | 1,119,854,192.86 | 1,117,702,137.61 | 1,120,286,883.32 | 1,121,174,067.89 |
| 少数股东权益 | 3,919,127.7 | - | 0 | - |
| 股东权益合计 | 1,123,773,320.56 | 1,117,702,137.61 | 1,120,286,883.32 | 1,121,174,067.89 |
| 负债和股东权益合计 | 1,191,878,228.71 | 1,232,886,207.33 | 1,279,716,015.89 | 1,213,947,013.65 |
| 公告日期 | 2026-08-26 | 2026-04-25 | 2026-04-25 | 2025-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |